In the latest session, Clearside Biomedical Inc. (NASDAQ: CLSD) closed at $1.18 up 3.51% from its previous closing price of $1.14. In other words, the price has increased by $+0.0400 from its previous closing price. On the day, 278694 shares were traded. CLSD stock price reached its highest trading level at $1.1900 during the session, while it also had its lowest trading level at $1.1115.
For a deeper understanding of Clearside Biomedical Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.50 and its Current Ratio is at 10.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
On July 29, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.
On May 13, 2020, ROTH Capital started tracking the stock assigning a Buy rating and target price of $8.ROTH Capital initiated its Buy rating on May 13, 2020, with a $8 target price.
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 17 when Hutson Nancy J bought 30,000 shares for $1.33 per share. The transaction valued at 39,900 led to the insider holds 83,000 shares of the business.
Deignan Charles A. sold 8,833 shares of CLSD for $18,461 on Jan 19. The Chief Financial Officer now owns 351,366 shares after completing the transaction at $2.09 per share. On Jan 19, another insider, Ciulla Thomas, who serves as the Chief Medical Officer of the company, sold 9,050 shares for $2.13 each. As a result, the insider received 19,276 and left with 295,260 shares of the company.
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.97 while its Price-to-Book (P/B) ratio in mrq is 3.81.
Stock Price History:
Over the past 52 weeks, CLSD has reached a high of $4.12, while it has fallen to a 52-week low of $1.00. The 50-Day Moving Average of the stock is 1.2266, while the 200-Day Moving Average is calculated to be 1.5497.
For the past three months, CLSD has traded an average of 182.58K shares per day and 533.42k over the past ten days. A total of 60.19M shares are outstanding, with a floating share count of 53.55M. Insiders hold about 11.02% of the company’s shares, while institutions hold 28.60% stake in the company. Shares short for CLSD as of Oct 13, 2022 were 495.81k with a Short Ratio of 0.53M, compared to 520.3k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 0.82% and a Short% of Float of 0.91%.
There are 5 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.03 for the current quarter, with a high estimate of $0.39 and a low estimate of -$0.15, while EPS last year was -$0.08. The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.12 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.02 and -$0.57 for the fiscal current year, implying an average EPS of -$0.43. EPS for the following year is -$0.62, with 5 analysts recommending between -$0.53 and -$0.8.
A total of 4 analysts have provided revenue estimates for CLSD’s current fiscal year. The highest revenue estimate was $33.23M, while the lowest revenue estimate was $700k, resulting in an average revenue estimate of $8.9M. In the same quarter a year ago, actual revenue was $29.57M, down -69.90% from the average estimate.